Are spatial tasks useful for the early diagnosis of Alzheimer’s disease.

Slides:



Advertisements
Similar presentations
Combining neuropsychology and genetics in the study of mood disorders Daniel Smith MRCPsych Division of Psychiatry, University of Edinburgh Specialist.
Advertisements

Emmanuel A Stamatakis Centre for Speech, Language and the Brain, Department of Experimental Psychology, University of Cambridge School of Psychological.
Speed of processing, the missing measure in early detection of MCI? Ruth O’Hara March 13 th 2001 Yogesh Shah.
Department of Neurology, Mayo Clinic Arizona
Living well with dementia: more timely diagnosis and early intervention Louise Robinson Professor of Primary Care and Ageing RCGP National Clinical Champion.
Frontotemporal Dementia
Presymptomatic HD Disease onset currently defined by clinical detection of motor abnormalities Questions: 1) Are more subtle but clinically important signs.
Dr Andrea Tales Research Fellow University of Bristol Department of Experimental Psychology Visual Attention-related processing in Mild Cognitive Impairment.
CSF tau Is it an informative biomarker of AD pathology Chris Clark Alzheimer’s Disease Center University of Pennsylvania.
Mental visual imagery – can a language encoded object generate depictive imagery? Igor Bascandziev Harvard Graduate School of Education.
Significance of White Matter Hyperintensities in MCI Charles DeCarli University of California at Davis Alzheimer’s Disease Center Imaging of Dementia and.
Alzheimer's Disease Your Name. Understanding Alzheimer's In 1906 Dr. Alois Alzheimer was first to describe Alzheimer's illness. Since then millions of.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
Mild Cognitive Impairment
Supporting Employees with Early Onset Dementias & other cognitive deficits Dr Miriam Prins Consultant Clinical Neuropsychologist Head of Older Adults Psychology.
Recognition of Dementia Syed Zaman Consultant Physician Geriatric Medicine Palmerston North Hospital.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
FTD Family Members Study & Post Mortem Study Alyson Negreira MGH Frontotemporal Disorders Unit.
New Learning and Remote Memory in Atypical Alzheimer’s Disease Yvonne Rogalski EXP 4504 December 3 rd, 2007 Thompson, Beswick, Foster, & Snowden (2003)
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
Mild Cognitive Impairment
How To Improve Memory Performance and Keep Your Brain Young Gary W. Small, MD Parlow-Solomon Professor on Aging Professor of Psychiatry & Biobehavioral.
Where is the semantic network?. What is the semantic network?  Knowledge of objects, people, concepts and word meanings  Spreading-activation theory.
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Delusions, behavioural symptoms, quality of life and caregiver effects in AD Delusions, behavioural symptoms, quality of life and caregiver effects in.
Alzheimer’s Disease  Goals  To understand what dementia is  To explore causes, risk factors, symptoms, and treatments of Alzheimer’s Disease  To better.
The Influence of Feature Type, Feature Structure and Psycholinguistic Parameters on the Naming Performance of Semantic Dementia and Alzheimer’s Patients.
September 2, 2009 Kamini Krishnan Tandra Toon. Article Focus Review of literature that combines use of functional or structural MRI and microelectrode.
Agnosia and Perceptual Disturbances March 27, 2006.
Wei Chen CCNI Journal Club Alzheimer’s disease (AD): imaging & cognition imaging & cognition.
Assessment and Diagnosis of Dementia Dr Alison Haddow.
Epidemiology of Alzheimer’s Disease
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
PharmaCog WP5 / E-ADNI. Enrollment and follow-ups Clinical sites Maximum Minimum PATIENTS EXPECTED.
Fear of Developing Dementia Kyle S. Page, MS, Bert Hayslip, Jr., PhD, Dee Wadsworth, MS.
Kimiko Domoto-Reilly, MD Cognitive / Behavioral Neurology Fellow Massachusetts General Hospital & Brigham and Women’s Hospital.
Mariano Musacchio 1 François Sellal 2 Frédéric Blanc 2 Jean-Marc Michel 2 Stephan Kremer 3 Jean-Louis Dietemann 3 1 Department of Neuroradiology - CHG.
A FMRI Episodic Memory Study A longitudinal protocol in 31 patients presenting with early memory complain F. Gelbert C. Belin, A.M. Ergis, C. Moroni, C.
Apolipoprotein E and Gray Matter Loss in Mild Cognitive Impairment and Alzheimer’s Disease Spampinato MV, Goldsberry G, Mintzer J, Rumboldt Z Medical University.
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
Alzheimer’s Disease (AD)
Advanced brain imaging and neurodegenerative disorders. Dott.ssa Ingrid Inches.
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
CASES SERIES BRAIN FDG PET SCAN IN DEMENTIA PATIENTS
Education Calendar Western Colorado Region April - June 2016 Healthy Living for Your Brain and Body: Tips from the Latest Research For centuries, we’ve.
Frontotemporal Lobar Degeneration:
This is an umbrella term, not a disease in its own right. It is a term used for a large group of symptoms that adversely affect the brain and can be caused.
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
All Hands Meeting 2004 Ontologies for Data Mediation Christine Fennema-Notestine, Ph.D.
The Malfunctioning Mind: Degenerative Diseases of the Brain
DEMENTIA Shenae Whitfield & Kate Maddock.
Rosa Maria Moresco University of Milan Bicocca
Memory Deficiency & Memory
Memory Deficiency & Memory
Use of Amyloid PET Scan in Early Diagnosis of Alzheimer’s Disease in a Secondary Care Memory Clinic Niki Schoonenboom, MD PhD1, Mohammed Akarriou, MD2;
Dementia Research and Enterprise at Liverpool John Moores University
Aging.
Dementia Jaqueline Raetz, M.D..
Cognitive Neuroscience and Dementia
Imaging AD Progression Amyloid Imaging Agents.
The need for the assessment of hearing loss as part of the dementia diagnosis Jenna Littlejohn Department of Neuroscience.
Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)
Early Cognitive Decline and the Aging Brain - Overview
Figure 2 Patterns of brain atrophy in Alzheimer disease
Early Dementia Distinguishing AD From MCI
Figure 2 Grey matter atrophy in FTD
Mark G. Baxter Involvement of Medial Temporal Lobe Structures in Memory and Perception.
Joseph I. Friedman et al. JIMG 2014;7:
Presentation transcript:

Are spatial tasks useful for the early diagnosis of Alzheimer’s disease

Talk Overview  A bit about my research interests in the field of dementia  Current research on use of spatial measures for diagnosis of dementia  Ideas for extending this research over the next few years

Frontotemporal Dementia  Semantic dementia (progressive fluent aphasia)  Anomia, impaired comprehension & loss of semantic knowledge, progresses to mutism  Frontal variant FTD  Changes in personality and social behaviour (lack of emphathy, increased risk-taking, poor social understanding)

Semantic dementia  Organisation of semantic memory and its relationship to language, perception and episodic memory (study breakdown of conceptual knowledge)  Visual and verbal memory in semantic dementia, and implications for relearning of names and associated conceptual knowledge (Graham et al., 2001; 2002; Dewar et al., in press)  Colour knowledge in semantic dementia (Rogers et al., 2007)  Letter-by-letter reading in semantic dementia (Cumming et al., 2006)

RealNonreal NR > R R > NR Colour knowledge

Theoretical model

Alzheimer’s disease  Profiles of memory impairment in Alzheimer’s disease, and how to map cognitive impairments onto early brain changes; development of sensitive measures for early diagnosis  Impairment in episodic memory (Simons et al., 2000; Scahill et al., 2005)  Spatial memory and discrimination (Lee et al., 2006; 2007)  Multidimensional measures for early diagnosis (Dudas et al., 2005; Clague et al., 2005) - tests of people naming, position identification and recognition memory

Recognition Memory Scenes mean % correct Considered low risk Considered high risk Taylor et al (in preparation) Face Scene % Correct MCI AD Chance

Oddity judgement Lee et al (2006) Faces Scenes mean % correct Semantic dementia Alzheimer’s disease Controls Oddity judgement

Current Research (Study 1)  Testing the sensitivity of spatial tests of memory and discrimination in early diagnosis of Alzheimer’s disease (being able to tell apart worried well from at high risk)  In collaboration with Tony Bayer (Geriatric Medicine)  Involves identifying cases at an early stage of disease (MMSE 28-30)  Testing performance of these individuals on a standard neuropsychological battery, and then an experimental battery of spatial tasks  Longitudinal follow-up of individuals to determine the usefulness of the tests in the clinic

Current Research (Study 2)  Attempting to link the cognitive impairments seen early on in Alzheimer’s disease with early structural and functional brain changes using fMRI  Tony Bayer (Geriatric Medicine) and Derek Jones (CUBRIC)  Subset of the cases from Study 1 in two fMRI studies  Oddity judgement with a recognition memory component (faces, objects and scenes)  Semantic knowledge of famous people (sensitive early in AD, Thompson et al., 2002)  Obtain high quality structural data (diffusion tensor imaging - allows modeling of the integrity of white matter tracts) and measure BOLD signal in key brain regions implicated early in Alzheimer’s disease  Why is this interesting…??

Posterior cingulate involvement in MCI Nestor et al (2003); Pengas et al (2008)

Parallels across imaging FDG-PET in MCI Nestor et al (2003) Scene Memory Taylor et al (2007) Scene Oddity Lee et al (2008)

Future plans  Neuroimaging and behavioural studies of the same tasks in individuals identifiable high risk of Alzheimer’s disease (ApoE, family history etc.), and in other types of dementia (semantic dementia)  Link this work to other potential biomarkers of early dementia (convergence and divergence) - genetic predispositions, proteins.  Better understanding variability in the normal aged population on these tasks: to gain a better feel for what is pathological or not.  Explore potential links between animal studies of AD and the clinical work (both neurosychology/neuroimaging); there is a real opportunity to test key new proposals about the genesis of pathology in AD in humans (posterior cingulate) in animals, with similar types of tasks

AD vs FvFTD A. Graham, Hodges & K. Graham (unpublished data)